Researchers from Hebei Medical University review current evidence on prolonged disorders of consciousness (pDOC) management. They propose a brain communication network model to explain how brain injury leads to long-term unconsciousness, identifying key brain electrical signaling activity measures for diagnosis and treatment.
SourceChinese Neurosurgical Journal·JournalChinese Neurosurgical Journal·TypeSystematic review·DateAug 17, 2026
Recent research explores the use of nanomaterial-based drug delivery to increase treatment efficacy for glioblastoma, a type of brain tumor with poor prognosis. Stimuli-responsive and biomimetic nanomedicines are designed to overcome the blood–brain barrier and deliver drugs selectively within tumors.
SourceChinese Neurosurgical Journal·JournalChinese Neurosurgical Journal·TypeSystematic review·DateAug 12, 2026
Researchers at UH College of Pharmacy are developing breakthroughs to combat sepsis, a leading cause of hospital deaths, and diseases such as Alzheimer's and sickle cell disease. A dual-action nanomedicine has shown a 100% survival rate in preclinical trials for sepsis treatment.
Apple iPhone 17 Pro
Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.
A multidisciplinary team of Penn researchers has developed a platform that delivers a combination of cancer-fighting therapies to treat oral squamous cell carcinoma. The findings show that the platform significantly reduces tumor burden and extends survival in aggressive, p53-therapy-resistant cancer models.
SourceUniversity of Pennsylvania·JournalAdvanced Materials·TypeExperimental study·DateJul 30, 2026
Emerging non-endocytic delivery strategies enable direct cytosolic delivery of proteins, nucleic acids, and gene-editing tools, providing new opportunities for biomedical therapies. The review discusses their application prospects in gene therapy, macromolecular drug delivery, and cellular engineering.
SourceBiomedical Analysis·JournalBiomedical Analysis·TypeLiterature review·DateJul 24, 2026
Researchers develop novel extracellular vesicle platform that makes bacteria more susceptible to polymyxins, enabling lower and safer treatment doses. The platform was shown to enhance bacterial killing and cause minimal toxicity in murine models.
SourcePusan National University·JournalDrug Resistance Updates·TypeExperimental study·DateJul 23, 2026
GQ GMC-500Plus Geiger Counter
GQ GMC-500Plus Geiger Counter logs beta, gamma, and X-ray levels for environmental monitoring, training labs, and safety demonstrations.
Tosyl groups act as a form of molecular code, enabling pseudorotaxane-like geometries and biased macrocyclization reactions. The number of tosyl units determines higher-order assembly behavior, including ring closure and polymeric chain formation.
SourceUniversity of Tsukuba·JournalJournal of the American Chemical Society·DateJul 20, 2026
Researchers developed a nanoparticle system that uses cancer cells' own copper resources to activate cuproptosis, eliminating tumor cells while protecting healthy tissue. The targeted nanoparticles showed enhanced cellular uptake and were more lethal to breast cancer cells than non-targeted versions.
SourceBiomedical Analysis·JournalBiomedical Analysis·TypeExperimental study·DateJul 15, 2026
Researchers developed nanoparticles that retain their protective coating in normal tissue but shed it upon reaching tumor tissue, releasing anticancer drugs. This technology reduces systemic side effects and enhances treatment efficacy.
SourcePohang University of Science & Technology (POSTECH)·JournalBiomaterials·DateJul 14, 2026
SAMSUNG T9 Portable SSD 2TB
SAMSUNG T9 Portable SSD 2TB transfers large imagery and model outputs quickly between field laptops, lab workstations, and secure archives.
Researchers developed a physics-informed neural network approach to predict material properties and optimize controlled-release systems. The new method requires significantly less data than traditional AI models, slashing development time for patches, bandages, and implants.
SourceBrown University·JournalJournal of Drug Delivery Science and Technology·DateJul 6, 2026
Researchers create tiny swimmers to deliver drugs through the human body, finding they reverse direction in non-Newtonian fluids like mucus and blood. This discovery enhances understanding of fluid behavior and could lead to targeted drug delivery.
SourceLehigh University·JournalApplied Physics Letters·DateJul 6, 2026
Expanding heart failure care to pharmacists and nurse practitioner-led medication management can save approximately 10 lives and prevent 25 hospitalizations per 1,000 patients. This service is estimated to be cost-effective and improve patient outcomes, providing a roadmap for a stronger healthcare system.
SourceElsevier·JournalCanadian Journal of Cardiology·TypeComputational simulation/modeling·DateJun 29, 2026
GoPro HERO13 Black
GoPro HERO13 Black records stabilized 5.3K video for instrument deployments, field notes, and outreach, even in harsh weather and underwater conditions.
Researchers developed a pH-triggered nanocomposite that synchronizes the release of therapeutic agents, combating bacterial biofilms and oxidative stress. The platform accelerates healing and promotes tissue repair in infected wounds.
SourceBiomedical Analysis·JournalBiomedical Analysis·TypeExperimental study·DateJun 25, 2026
Researchers developed mathematical models and simulations to predict the behavior of a unique drug-delivery method, aiming to reduce medication side effects while increasing treatment efficacy. The method uses magnetic particles to guide cell-like drug carriers toward specific targets in the body.
SourceFlorida State University·JournalPhysical Review Letters·DateJun 24, 2026
A recent study found that the FDA approval of semaglutide for weight management led to a significant increase in calls to poison control centers, with over 8,000 cases reported by 2023. The majority of errors were preventable and stemmed from unintentional dosing or therapeutic mistakes.
SourceUniversity of Texas at San Antonio·JournalJournal of Medical Toxicology·DateJun 23, 2026
DJI Air 3 (RC-N2)
DJI Air 3 (RC-N2) captures 4K mapping passes and environmental surveys with dual cameras, long flight time, and omnidirectional obstacle sensing.
Researchers developed an injectable hydrogel combining silk proteins and a kudzu plant compound, achieving complete wound closure within 72 hours. The material's mechanical stability and cell viability exceeded expectations.
SourceTerasaki Institute for Biomedical Innovation·JournalACS Omega·TypeExperimental study·DateJun 22, 2026
Researchers designed artificial proteins that simultaneously form pentagonal and hexagonal arrangements to create virus-like structures. These structures can stably carry drugs, genetic materials, and enzymes within their interior space.
SourcePohang University of Science & Technology (POSTECH)·JournalNature·DateJun 17, 2026
Researchers at the University of Houston have discovered adding salt can help release therapeutic material from endosomes, improving delivery efficiency for mRNA vaccines and gene therapies. The simple strategy overcomes a major obstacle in gene medicine, potentially making these therapies more efficient and accessible worldwide.
The University of Virginia has joined SPARK GLOBAL to leverage resources and expertise in accelerating the development of new medicines. This collaboration aims to reduce time from lab discoveries to clinic trials, delivering tangible healthcare solutions to patients.
Researchers create a hydrogel-based oral formulation that coats the esophageal lining and releases antibodies like infliximab to treat inflammatory conditions. The formulation reduces side effects by temporarily loosening cell-cell junctions, allowing larger molecules to pass through.
SourceMassachusetts Institute of Technology·JournalNature Biomedical Engineering·DateJun 12, 2026
AmScope B120C-5M Compound Microscope
AmScope B120C-5M Compound Microscope supports teaching labs and QA checks with LED illumination, mechanical stage, and included 5MP camera.
A recent study by Semmelweis University found that alkaline mineral and medicinal waters can weaken the enteric coating of medications, reducing their effectiveness. The study analyzed 22 beverages and found that tap water was less damaging to the coating than acidic or alkaline liquids.
SourceSemmelweis University·JournalPharmaceutics·DateJun 10, 2026
MIT researchers have developed low-cost, 3D-printed triaxial electrospray emitters that efficiently produce three-layered particles at scale. The devices can be used to manufacture time-release drug-delivery nanoparticles with potential applications in biosensors and tissue regeneration.
SourceMassachusetts Institute of Technology·JournalVirtual and Physical Prototyping·DateJun 10, 2026
Researchers identify key mechanisms and molecular targets to prevent tumor progression in patients with rhabdomyosarcoma, a rare soft tissue cancer affecting young children. Two new treatment possibilities have been highlighted, targeting the IRE1α-XBP1 signaling axis and protein TAK1.
SourceUniversity of Houston·JournalCommunications Biology·DateJun 9, 2026
Researchers developed anisotropy-tunable mesoporous polydopamine nanomotors with POM-mediated assembly, which combine intrinsic antibacterial activity, self-propulsion, and high drug-loading capacity. These nanomotors demonstrate enhanced antibacterial efficiency and biofilm eradication against drug-resistant bacterial biofilms.
SourceScience China Press·JournalNational Science Review·TypeExperimental study·DateJun 8, 2026
Davis Instruments Vantage Pro2 Weather Station
Davis Instruments Vantage Pro2 Weather Station offers research-grade local weather data for networked stations, campuses, and community observatories.
Researchers at UMass Amherst have designed a new therapy that combines engineered Salmonella bacteria with oncolytic viruses to target liver and pancreatic cancer. The treatment showed promising results in animal models, leading to significant tumor reduction and improved survival rates.
SourceUniversity of Massachusetts Amherst·JournalCell Reports Medicine·TypeRandomized controlled/clinical trial·DateJun 3, 2026
The study uses DNA barcodes to track and compare dozens of gold nanoparticle designs in living tumour models, identifying those effective at reaching mitochondria. Two formulations emerged as standout performers, achieving high tumour regression when combined with RNA therapy and photothermal treatment.
SourceNational University of Singapore·JournalAdvanced Materials·DateMay 11, 2026
The ERASur clinical trial is investigating whether total ablative therapy can improve overall survival in patients with newly diagnosed, limited metastatic colorectal cancer. The study has reached one-third patient accrual milestone, signaling strong momentum.
SourceAlliance for Clinical Trials in Oncology·TypeRandomized controlled/clinical trial·DateMay 6, 2026
Kestrel 3000 Pocket Weather Meter
Kestrel 3000 Pocket Weather Meter measures wind, temperature, and humidity in real time for site assessments, aviation checks, and safety briefings.
The ASPIRE trial aims to enroll 1,200 participants with advanced prostate cancer and assess the impact of chemotherapy on overall survival and disease progression. Genetic profiling is included to identify patients who benefit most from intensified treatment.
SourceAlliance for Clinical Trials in Oncology·DateMay 4, 2026
Chronic liver disease in the US costs $41.57 billion, with prescription medication expenditures accounting for nearly half of all-cause healthcare expenditures. Poor adherence to antiviral medications is a key factor in preventing disease progression and treatment, with high out-of-pocket costs increasing non-adherence risk.
SourceUniversity of Houston·JournalExpert Review of Pharmacoeconomics & Outcomes Research·DateApr 28, 2026
Researchers Dr Íris Luz Batalha and Dr Maria Shchepinova from the University of Bath have been awarded funding to test new ideas in tackling global health challenges. They will develop precision-targeted therapies for antimicrobial resistance and investigate why treatments for Type 2 diabetes don't work for everyone.
CalDigit TS4 Thunderbolt 4 Dock
CalDigit TS4 Thunderbolt 4 Dock simplifies serious desks with 18 ports for high-speed storage, monitors, and instruments across Mac and PC setups.
Researchers developed a nasal spray that reversibly reduces brain inflammation, restores cellular power plants, and improves memory. The treatment bypasses the brain's protective shield through intranasal delivery, suppressing chronic inflammation and promoting successful brain aging.
SourceTexas A&M University·JournalJournal of Extracellular Vesicles·DateApr 14, 2026
A comprehensive review reveals how phospholipid asymmetry governs EV surface charge, providing a unified framework for classification, functional understanding, and standardization in nanomedicine. The study highlights the importance of membrane lipid composition and surface charge in determining EV function.
SourceInnovation Center of NanoMedicine·JournalACS Nano Medicine·TypeSystematic review·DateApr 14, 2026
Researchers have combined ion pumps with click-to-release chemistry to enable precise electronic control of drug release for a broader range of therapeutics. This technology allows for targeted local therapy with lower doses, reducing side effects.
SourceVienna University of Technology·JournalNature Communications·TypeExperimental study·DateApr 13, 2026
Fluke 87V Industrial Digital Multimeter
Fluke 87V Industrial Digital Multimeter is a trusted meter for precise measurements during instrument integration, repairs, and field diagnostics.
Researchers at Terasaki Institute for Biomedical Innovation develop a smart contact lens that monitors intraocular pressure in real time and delivers treatment. The technology has shown promising results in preclinical models and aims to improve quality of life for patients with ocular diseases.
SourceTerasaki Institute for Biomedical Innovation·JournalScience Translational Medicine·TypeExperimental study·DateApr 8, 2026
A randomized trial found that duloxetine does not prevent painful neuropathy caused by oxaliplatin-based chemotherapy in patients with stage II or III colorectal cancer. The study suggests that duloxetine should only be used for managing existing neuropathy, not prevention.
SourceAlliance for Clinical Trials in Oncology·JournalJCO Oncology Advances·TypeRandomized controlled/clinical trial·DateApr 8, 2026
Researchers at the University of Mississippi have developed a new method for delivering cancer-fighting drugs using 3D-printed nanocarriers, which can target specific tumor sites and minimize side effects. This innovative approach has shown promising results in killing cancer cells and reducing the impact of traditional chemotherapy.
SourceUniversity of Mississippi·JournalPharmaceutical Research·DateApr 6, 2026
The Alliance for Clinical Trials in Oncology is enrolling adolescent and young adult cancer patients in various trials, including genetic services and treatment studies. These trials aim to address longstanding gaps in care and improve outcomes for AYAs with cancer.
SourceAlliance for Clinical Trials in Oncology·DateApr 6, 2026
A new study from Oregon State University has found a way to treat both lung cancer and associated muscle-wasting cachexia using lipid nanoparticles. The treatment involves loading the nanoparticles with follistatin messenger RNA, which triggers cells to produce the protein, promoting muscle tissue growth while inhibiting tumors.
SourceOregon State University·JournalJournal of Controlled Release·TypeExperimental study·DateApr 6, 2026
Apple MacBook Pro 14-inch (M4 Pro)
Apple MacBook Pro 14-inch (M4 Pro) powers local ML workloads, large datasets, and multi-display analysis for field and lab teams.
Researchers found that clearing intestinal commensal bacteria improves delivery efficiency of various carriers, including polymeric nanoparticles and viral vectors. This study offers a new approach to enhance therapeutic effects in tumor chemotherapy and gene therapy.
SourceChinese Academy of Sciences Headquarters·JournalScience·DateMar 30, 2026
A new system generates oxygen, sustaining drug-producing cells for weeks. The device, called HOBIT, integrates engineered cells with oxygen-producing bioelectronics, producing three different biologics in a small animal model.
SourceNorthwestern University·JournalDevice·DateMar 27, 2026
Early-stage drug development has nearly doubled globally over the past decade, driven by a shift from a US-dominated system to a two-hub structure. This change may have implications for scientific workforce development, investment, and patient access to new therapies.
Apple AirPods Pro (2nd Generation, USB-C)
Apple AirPods Pro (2nd Generation, USB-C) provide clear calls and strong noise reduction for interviews, conferences, and noisy field environments.
Researchers have identified and overcome metabolic instability as the key barrier to developing ovalicin, a potent relative of fumagillin. Using chem-bio hybrid synthesis, they created metabolically stable drug candidates that worked in animal models of amebiasis.
SourceNagoya University·JournalJournal of the American Chemical Society·TypeExperimental study·DateMar 26, 2026
A new approach allows oral delivery of drugs previously requiring injection by piggybacking on natural fat absorption pathways. The medication, GlyphAllo, bypasses the liver's security checkpoint and is absorbed through the gut's lymphatic system, allowing it to enter the bloodstream directly.
SourceMonash University·JournalScience Translational Medicine·TypeRandomized controlled/clinical trial·DateMar 25, 2026
A systematic scoping review found that social media influencer promotion of prescription drugs carries risks of inaccurate or misleading advice. The study emphasizes the need for updated guidelines and digital literacy initiatives to safeguard public health.
SourceJAMA Network·JournalJAMA Network Open·DateMar 23, 2026
Researchers have discovered a simple fix to boost mRNA delivery and CRISPR gene editing efficiency by adding three common amino acids to lipid nanoparticle injections, increasing delivery up to 20-fold and efficiency to nearly 90%.
SourceBiohub·JournalScience Translational Medicine·TypeExperimental study·DateMar 11, 2026
The Alliance for Clinical Trials in Oncology is spotlighting new trials for colorectal cancer in March, focusing on early detection methods and treatments for treatment delays and loss of appetite. The trials aim to improve patient outcomes, with several enrolling patients with newly diagnosed colon or rectal cancer.
SourceAlliance for Clinical Trials in Oncology·DateMar 8, 2026
Sky & Telescope Pocket Sky Atlas, 2nd Edition
Sky & Telescope Pocket Sky Atlas, 2nd Edition is a durable star atlas for planning sessions, identifying targets, and teaching celestial navigation.
A new injection therapy uses self-amplifying RNA to prompt the body's release of the natural heart-protective hormone ANP for several weeks. This approach aims to reduce harmful scarring, preserve healthy heart muscle and improve heart function after a heart attack.
SourceTexas A&M University·JournalScience·DateMar 5, 2026
Researchers design nanoagents to carry antibiotics deep into bacterial infections, releasing them upon gentle ultrasound activation. This approach reduces antibiotic resistance and improves treatment of biofilm-related infections.
SourceUniversity of Birmingham·JournalJACS Au·TypeExperimental study·DateMar 2, 2026
Researchers developed a light-responsive nanoassembly that enables precise and controllable drug delivery inside tumor cells. The strategy achieves strong tumor suppression while effectively inhibiting tumor spread, without causing noticeable systemic toxicity.
SourceScience China Press·JournalScience Bulletin·DateMar 2, 2026
A new study shows that valved holding chambers used to deliver medication to children with acute respiratory diseases differ markedly in their performance. The choice of device can affect treatment outcomes, with higher delivery devices resulting in lower hospital admissions and better physiological recovery.
SourceTampere University·JournalJAMA Pediatrics·DateFeb 24, 2026
Researchers identified genes that are activated when yeast cells are in the gut, suggesting a roadmap for engineering more efficient drug-delivery vehicles. The study found that yeast cells were digesting more lipids than carbohydrates in the gut, highlighting potential modifications to improve efficiency.
SourceNorth Carolina State University·JournalBMC Genomics·TypeExperimental study·DateFeb 24, 2026
Nikon Monarch 5 8x42 Binoculars
Nikon Monarch 5 8x42 Binoculars deliver bright, sharp views for wildlife surveys, eclipse chases, and quick star-field scans at dark sites.
Researchers at Tokyo Metropolitan University have created a neutral molecule that can carry DNA into biological cells using a process called annealing. This breakthrough promises more effective therapies by reducing inflammation and improving delivery efficiency.
SourceTokyo Metropolitan University·JournalACS Applied Bio Materials·DateFeb 21, 2026
A new study finds salcaprozate sodium may have adverse biological effects on the gut and beyond, including shifts in potentially harmful gut bacteria and elevated inflammatory markers. The research highlights an important gap in understanding the long-term impact of repeated SNAC exposure.
SourceAdelaide University·JournalJournal of Controlled Release·DateFeb 17, 2026
A recent study reveals that hydration and terminal chemistry of poly(ethylene) glycol (PEG) polymers influence immune recognition, providing insights into why some PEGylated drug coatings fail to evade the immune system. The findings pave the way for novel drug coatings with improved performance.
SourceInstitute of Science Tokyo·JournalACS Applied Bio Materials·TypeExperimental study·DateFeb 16, 2026
The University of Missouri has launched its first human clinical trial using Eye90 microspheres, a radiopharmaceutical breakthrough device manufactured on campus. The study aims to assess the safety and effectiveness of Eye90 in treating unresectable liver tumors, including hepatocellular carcinoma and metastatic colorectal cancer.
Apple Watch Series 11 (GPS, 46mm)
Apple Watch Series 11 (GPS, 46mm) tracks health metrics and safety alerts during long observing sessions, fieldwork, and remote expeditions.
Researchers quantify interactions of P407 micelles in PBS to understand gelation behavior and release mechanisms. The study reveals stronger attractive forces between micelles in saline, affecting gel stability and structural fluctuations.
SourceChiba University·JournalJournal of Colloid and Interface Science·TypeExperimental study·DateFeb 9, 2026
Researchers have developed a long, needle-thin brain electrode with channels that enables neural signal recording and precisely targeted medication delivery across different brain regions. The technology has primarily been developed for basic research but may be important for future treatments in epilepsy and other neurological diseases.
SourceTechnical University of Denmark·JournalAdvanced Science·DateFeb 5, 2026
A new study offers hope that kidney transplant patients may one day have a more effective treatment regimen. The Phase 2 pilot study showed improved kidney functioning in all patients who completed the study, with no patients experiencing rejection due to antibodies produced by the immune system.
SourceUniversity of California - San Francisco·JournalAmerican Journal of Transplantation·DateFeb 3, 2026
Sony Alpha a7 IV (Body Only)
Sony Alpha a7 IV (Body Only) delivers reliable low-light performance and rugged build for astrophotography, lab documentation, and field expeditions.
The UH College of Pharmacy is expanding its graduate program to offer a Doctor of Philosophy and Master of Science in Population Health & Pharmacoepidemiology, addressing a growing demand for training in evaluating medication safety and effectiveness.
Researchers developed a solvent-free method to enhance drug bioavailability by transitioning from solid to gas phase. The sealed heating (SH) method increases drug solubility without using organic solvents.
SourceTokyo University of Science·JournalJournal of Pharmaceutical Sciences·TypeExperimental study·DateJan 30, 2026